Clinical Trial

Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-11-13; most recent amendment 2026-04-15.
Status change: Recruiting → Active, Not Recruiting 2025-11-17
Trial Details
NCT Number NCT06138613
Lead Sponsor Vanda Pharmaceuticals
Conditions Motion Sickness
Enrollment 705 participants
Start Date 2023-02-27
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-16